L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
Efficacy of Endolysin in Atopic Dermatitis
- 2min
- Supported by
Ann’Laure Demessant
Scientific communication director, La Roche-Posay
Today, we know that bacteria, such as Staphylococcus Aureus, can cause inflammation and worsen eczema symptoms. This is a newly identified aggravating factor.
Endobioma ingredient, included in LIPIKAR ECZEMA MED, is a derivative of a natural mechanism used by micro-organisms against bacteria and its specifically targets Staphylococcus Aureus bacteria.
La Roche-Posay has conducted studies on LIPIKAR ECZEMA MED that confirm the quick relief of signs & symptoms such as itching & burning, with a great improvement in quality of life.
Scientific communication director, La Roche-Posay
Discover the publication key messages
Atopic dermatitis is an increasingly common skin condition that affects children & adults and has an impact on the quality of life.Today, we know that bacteria, such as Staphylococcus Aureus, can cause inflammation and worsen eczema symptoms. This is a newly identified aggravating factor.
Endobioma ingredient, included in LIPIKAR ECZEMA MED, is a derivative of a natural mechanism used by micro-organisms against bacteria and its specifically targets Staphylococcus Aureus bacteria.
La Roche-Posay has conducted studies on LIPIKAR ECZEMA MED that confirm the quick relief of signs & symptoms such as itching & burning, with a great improvement in quality of life.